William Fairey
Direktor/Vorstandsmitglied bei MIRUM PHARMACEUTICALS, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von William Fairey
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MIRUM PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 19.08.2021 | - |
Independent Dir/Board Member | 19.08.2021 | - | |
ASCENDIS PHARMA A/S | Direktor/Vorstandsmitglied | 01.09.2022 | - |
Independent Dir/Board Member | 01.09.2022 | - | |
AILERON THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 31.10.2023 | - |
Independent Dir/Board Member | 31.10.2023 | - | |
KALVISTA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 18.04.2024 | - |
Actelion Pharmaceuticals Trading (Shanghai) Co. Ltd. | Direktor/Vorstandsmitglied | - | - |
Respira Therapeutics, Inc.
Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Respira Therapeutics, Inc. engages in provision of pulmonary delivery of therapeutics for respiratory diseases. Its technology Dry Powder Inhaler (DPI), deliver dry powder drug products to the lung more effectively than other DPI technologies. The company was founded in 2010 and is headquartered in Albuquerque, NM. | Vorsitzender | 01.01.2022 | - |
Karriereverlauf von William Fairey
Ehemalige bekannte Positionen von William Fairey
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Lung Therapeutics, Inc.
Lung Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lung Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in the development and commercialization of drugs for lung injury and disease. Its product pipelines include LTI-03 for the treatment of Idiopathic Pulmonary Fibrosis and LTI-01 for Loculated Pleural Effusion. The company was founded by Steven Idell and Andrew Mazar in 2012 and is headquartered in Austin, TX. | Direktor/Vorstandsmitglied | 31.08.2021 | 31.10.2023 |
MYOKARDIA, INC. | Corporate Officer/Principal | 01.01.2019 | 01.11.2020 |
CHEMOCENTRYX, INC. | Geschäftsführer | 08.01.2018 | 18.01.2019 |
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von William Fairey
St. Mary's College of California | Masters Business Admin |
University of Oregon | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 11 |
Dänemark | 2 |
Australien | 2 |
Operativ
Director/Board Member | 6 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 3 |
Sektoral
Health Technology | 11 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
AILERON THERAPEUTICS, INC. | Health Technology |
ASCENDIS PHARMA A/S | Health Technology |
KALVISTA PHARMACEUTICALS, INC. | Health Technology |
MIRUM PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 9 |
---|---|
ChemoCentryx, Inc.
ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
MyoKardia, Inc.
MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
Lung Therapeutics, Inc.
Lung Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lung Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in the development and commercialization of drugs for lung injury and disease. Its product pipelines include LTI-03 for the treatment of Idiopathic Pulmonary Fibrosis and LTI-01 for Loculated Pleural Effusion. The company was founded by Steven Idell and Andrew Mazar in 2012 and is headquartered in Austin, TX. | Health Technology |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
Australia Asia Pacific Hotels Ltd.
Australia Asia Pacific Hotels Ltd. Hotels/Resorts/Cruise linesConsumer Services Australia Asia Pacific Hotels Ltd. is an Australian private company located in Sydney. The firm operates hotels. | Consumer Services |
Respira Therapeutics, Inc.
Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Respira Therapeutics, Inc. engages in provision of pulmonary delivery of therapeutics for respiratory diseases. Its technology Dry Powder Inhaler (DPI), deliver dry powder drug products to the lung more effectively than other DPI technologies. The company was founded in 2010 and is headquartered in Albuquerque, NM. | Health Technology |
Actelion Pharmaceuticals Canada, Inc. | |
Actelion Pharmaceuticals Ltd.
Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Ltd. is a Swiss company that develops and distributes molecular weight drugs. The company is based in Allschwil, Switzerland. | Health Technology |
Actelion Pharmaceuticals Trading (Shanghai) Co. Ltd. |
- Börse
- Insiders
- William Fairey
- Erfahrung